WP
PCRX icon

WealthPLAN Partners’s Pacira BioSciences PCRX Stock Holding History

WealthPLAN Partners’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8
Closed -$321 – 891
2023
Q2 		$321 Hold
8
– – ﹤0.01% 1199
2023
Q1 		$326 Buy
+8
New +$318 ﹤0.01% 1266
2016
Q3 		– Sell
-38
Closed -$1 – 1046
2016
Q2 		$1 Buy
+38
New +$1.87K ﹤0.01% 2584
2015
Q4 		$6 Buy
+76
New +$4.3K ﹤0.01% 1728
2015
Q2 		$3K Sell
38
-262
-87% -$20.6K ﹤0.01% 370
2015
Q1 		$27K Buy
+300
New +$30.4K 0.01% 295

Other funds holding PCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return